Name: UMIN ID:
Unique ID issued by UMIN | UMIN000009910 |
---|---|
Receipt number | R000011612 |
Scientific Title | A phaseII study of irinotecan with bevacizumab as third line treatment for patients with metastatic colorectal cancer after failure to irinotecan who have progressed on bevacizumab with oxaliplatin-based chemotherapy in second line. |
Date of disclosure of the study information | 2013/01/30 |
Last modified on | 2018/08/14 01:15:14 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2013/01/30 20:38:49 | ||
2 | Update | 2013/05/30 11:03:01 | Key inclusion criteria Key inclusion criteria |
|
3 | Update | 2018/08/14 01:15:14 | Recruitment status |